290 related articles for article (PubMed ID: 34643248)
1. Berberine exerts its antineoplastic effects by reversing the Warburg effect via downregulation of the Akt/mTOR/GLUT1 signaling pathway.
Guo XH; Jiang SS; Zhang LL; Hu J; Edelbek D; Feng YQ; Yang ZX; Hu PC; Zhong H; Yang GH; Yang F
Oncol Rep; 2021 Dec; 46(6):. PubMed ID: 34643248
[TBL] [Abstract][Full Text] [Related]
2. Berberine targets KIF20A and CCNE2 to inhibit the progression of nonsmall cell lung cancer via the PI3K/AKT pathway.
Wang Q; Wu H; Wu Q; Zhong S
Drug Dev Res; 2023 Aug; 84(5):907-921. PubMed ID: 37070571
[TBL] [Abstract][Full Text] [Related]
3. Berberine regulates mesangial cell proliferation and cell cycle to attenuate diabetic nephropathy through the PI3K/Akt/AS160/GLUT1 signalling pathway.
Ni WJ; Guan XM; Zeng J; Zhou H; Meng XM; Tang LQ
J Cell Mol Med; 2022 Feb; 26(4):1144-1155. PubMed ID: 35001506
[TBL] [Abstract][Full Text] [Related]
4. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
[TBL] [Abstract][Full Text] [Related]
5. Berberine regulates the Notch1/PTEN/PI3K/AKT/mTOR pathway and acts synergistically with 17-AAG and SAHA in SW480 colon cancer cells.
Li G; Zhang C; Liang W; Zhang Y; Shen Y; Tian X
Pharm Biol; 2021 Dec; 59(1):21-30. PubMed ID: 33417512
[TBL] [Abstract][Full Text] [Related]
6. Different mechanisms involved in the berberine-induced antiproliferation effects in triple-negative breast cancer cell lines.
Lin YS; Chiu YC; Tsai YH; Tsai YF; Wang JY; Tseng LM; Chiu JH
J Cell Biochem; 2019 Aug; 120(8):13531-13544. PubMed ID: 30957305
[TBL] [Abstract][Full Text] [Related]
7. Pharmacotranscriptomic profiling of resistant triple-negative breast cancer cells treated with lapatinib and berberine shows upregulation of PI3K/Akt signaling under cytotoxic stress.
Jabbarzadeh Kaboli P; Luo S; Chen Y; Jomhori M; Imani S; Xiang S; Wu Z; Li M; Shen J; Zhao Y; Wu X; Hin Cho C; Xiao Z
Gene; 2022 Mar; 816():146171. PubMed ID: 35026293
[TBL] [Abstract][Full Text] [Related]
8. Effects of Glut1 gene silencing on proliferation, differentiation, and apoptosis of colorectal cancer cells by targeting the TGF-β/PI3K-AKT-mTOR signaling pathway.
Wu XL; Wang LK; Yang DD; Qu M; Yang YJ; Guo F; Han L; Xue J
J Cell Biochem; 2018 Feb; 119(2):2356-2367. PubMed ID: 28884839
[TBL] [Abstract][Full Text] [Related]
9. Berberine represses human gastric cancer cell growth in vitro and in vivo by inducing cytostatic autophagy via inhibition of MAPK/mTOR/p70S6K and Akt signaling pathways.
Zhang Q; Wang X; Cao S; Sun Y; He X; Jiang B; Yu Y; Duan J; Qiu F; Kang N
Biomed Pharmacother; 2020 Aug; 128():110245. PubMed ID: 32454290
[TBL] [Abstract][Full Text] [Related]
10. Berberine attenuates apoptosis in rat retinal Müller cells stimulated with high glucose via enhancing autophagy and the AMPK/mTOR signaling.
Chen H; Ji Y; Yan X; Su G; Chen L; Xiao J
Biomed Pharmacother; 2018 Dec; 108():1201-1207. PubMed ID: 30372821
[TBL] [Abstract][Full Text] [Related]
11. Berberine Targets AP-2/hTERT, NF-κB/COX-2, HIF-1α/VEGF and Cytochrome-c/Caspase Signaling to Suppress Human Cancer Cell Growth.
Fu L; Chen W; Guo W; Wang J; Tian Y; Shi D; Zhang X; Qiu H; Xiao X; Kang T; Huang W; Wang S; Deng W
PLoS One; 2013; 8(7):e69240. PubMed ID: 23869238
[TBL] [Abstract][Full Text] [Related]
12. Berberine decelerates glucose metabolism via suppression of mTOR‑dependent HIF‑1α protein synthesis in colon cancer cells.
Mao L; Chen Q; Gong K; Xu X; Xie Y; Zhang W; Cao H; Hu T; Hong X; Zhan YY
Oncol Rep; 2018 May; 39(5):2436-2442. PubMed ID: 29565467
[TBL] [Abstract][Full Text] [Related]
13. Exploring the active mechanism of berberine against HCC by systematic pharmacology and experimental validation.
Song L; Luo Y; Wang X; Almutairi MM; Pan H; Li W; Liu Y; Wang Q; Hong M
Mol Med Rep; 2019 Nov; 20(5):4654-4664. PubMed ID: 31545468
[TBL] [Abstract][Full Text] [Related]
14. DT-13 inhibited the proliferation of colorectal cancer via glycolytic metabolism and AMPK/mTOR signaling pathway.
Wei X; Mao T; Li S; He J; Hou X; Li H; Zhan M; Yang X; Li R; Xiao J; Yuan S; Sun L
Phytomedicine; 2019 Feb; 54():120-131. PubMed ID: 30668361
[TBL] [Abstract][Full Text] [Related]
15. FoxO proteins' nuclear retention and BH3-only protein Bim induction evoke mitochondrial dysfunction-mediated apoptosis in berberine-treated HepG2 cells.
Shukla S; Rizvi F; Raisuddin S; Kakkar P
Free Radic Biol Med; 2014 Nov; 76():185-99. PubMed ID: 25128467
[TBL] [Abstract][Full Text] [Related]
16. Berberine in combination with cisplatin induces necroptosis and apoptosis in ovarian cancer cells.
Liu L; Fan J; Ai G; Liu J; Luo N; Li C; Cheng Z
Biol Res; 2019 Jul; 52(1):37. PubMed ID: 31319879
[TBL] [Abstract][Full Text] [Related]
17. Berberine inhibits the proliferation, invasion and migration of endometrial stromal cells by downregulating miR‑429.
Gu Y; Zhou Z
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33846796
[TBL] [Abstract][Full Text] [Related]
18. Atractylenolide I inhibits colorectal cancer cell proliferation by affecting metabolism and stemness via AKT/mTOR signaling.
Wang K; Huang W; Sang X; Wu X; Shan Q; Tang D; Xu X; Cao G
Phytomedicine; 2020 Mar; 68():153191. PubMed ID: 32135457
[TBL] [Abstract][Full Text] [Related]
19. A gene expression signature-based approach reveals the mechanisms of action of the Chinese herbal medicine berberine.
Lee KH; Lo HL; Tang WC; Hsiao HH; Yang PM
Sci Rep; 2014 Sep; 4():6394. PubMed ID: 25227736
[TBL] [Abstract][Full Text] [Related]
20. Halofuginone inhibits colorectal cancer growth through suppression of Akt/mTORC1 signaling and glucose metabolism.
Chen GQ; Tang CF; Shi XK; Lin CY; Fatima S; Pan XH; Yang DJ; Zhang G; Lu AP; Lin SH; Bian ZX
Oncotarget; 2015 Sep; 6(27):24148-62. PubMed ID: 26160839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
